Larson Financial Group LLC Day One Biopharmaceuticals, Inc. Transaction History
Larson Financial Group LLC
- $2.12 Billion
- Q1 2025
A detailed history of Larson Financial Group LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 76 shares of DAWN stock, worth $591. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76Holding current value
$591% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
177Shares Held
75.4MCall Options Held
140KPut Options Held
253K-
Atlas Venture Life Science Advisors, LLC6.43MShares$50 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$45.5 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$44.8 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$37.9 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$35.3 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $572M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...